Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according...
Study assesses blood test to match patients to clinical trials
Researchers from the University of Manchester’s CRUK Manchester Institute are conducting a clinical study, dubbed TARGET, to evaluate the use of a blood test in matching cancer patients to appropriate clinical trials.
FDA, Brigham and Women’s Hospital expand RCT DUPLICATE project
The US Food & Drug Administration (FDA) and Brigham and Women's Hospital have expanded their previous RCT DUPLICATE demonstration project to predict the results of seven Phase IV trials that are currently ongoing.